TrialJournal of clinical immunology2006

Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study.

Ann Gardulf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.